Accelerating the development of life-saving treatments

The respiratory treatment pipeline has stalled. Access to innovative new treatments has never been more needed.

Lung conditions are the third biggest killer in the UK. We can’t afford to slow down the search for life-saving treatments when people are still fighting for breath.

We want to see development of new drugs through the reintroduction of more clinical trials to the UK via a connected platform.

We’re calling for:

  • A £4 million investment to revitalise experimental medical research and make the UK the best place for large-scale clinical trials.
  • More clinical trials in the UK via a connected platform to accelerate the development of new drugs and therapeutic targets.
  • A commitment to further the role of technologies such as AI, quantum computing and regenerative medicine in identifying potential treatments and therapies.